chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a non-contactable other health care professional. A 52-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 16Feb2021 ((at the age of 52 years old)) (Batch/Lot Number: EN5318) as dose 2, single and via an unspecified route of administration on 22Jan2021 (at the age of 52 years old) (Batch/Lot Number: EN5318) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 05Aug2021, the patient was tested positive for covid-19 following completion of covid-19 vaccine series. The adverse event resulted in Doctor or other healthcare professional office or clinic visit. It is unknown if the patient received any treatment for the adverse events. It is unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine and unknown if the patient was diagnosed with COVID-19 prior to the vaccination and has been tested for COVID-19 since the vaccination. The patient underwent lab tests and procedures which included sars-cov-2 test positive on 05Aug2021. Covid test type Unknown. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected. Sender's Comments: Based on known drug safety profile and temporal association, there is reasonable possibility of causal association between the events vaccination failure, covid-19 and the suspect drug BNT162B2.
Gradual increased redness with ? at injection site involving entire extremity over 3-4 days removed.
On 12/06/2022 at around 02:00PM. I was vomiting and I had diarrhea for 8 hours. On 12/07/2022 around 02:30PM I went to the emergency room. The stomach virus caused me to have AFIB. My electrolyte's were out and I felt weak. They gave me 2 diltiazem and IV fluids. After 6 hours I was discharged from the hospital. It happened 1 month after my 5th dose. The Cardiologist have remote monitoring on my pace maker so they can see everything happening to my body. My heart was racing so they changed medications around to control it. I am still under treatment for AFIB.
I had my first vaccine on the 3/9/2021 Pfizer - Biontech ENG199 and am scheduled to have the second injection on the 3/30/2021  I had a slight arm pain 5 hours after the injection that wen away after 30 hours  However on 3/15/2021 I had began to experience a stiff neck on the left side (I had the injection on the left side)  Later on the evening of the 3/19/2021 I began to experience pressure in the left ear which is still persistant today.  I really never had these issues before is this from the vaccine?  What should I do?
Client came in and requested the 3 vaccines we were providing at the outreach: Menveo (MenACWY), Havrix (Hepatitis A), and Jynneos (MPox). After receiving the 3 vaccines, client went to the front waiting room and notified one of the staff that he was feeling lightheaded, dizzy, and unwell. Client was brought to an exam room, was laid down, assessed by staff, and provided an electrolyte beverage. Client notified staff that he had not eaten that day yet, and had taken a 5mg Valium before coming to the vaccination event. EMS was called and showed up to assess the client. After assessment, the client ended up being transported via EMS to hospital. Client was vaccinated at approximately 12:30pm. Client notified staff he was feeling unwell around 12:35pm. EMS was called at 1:23pm. EMS showed up at 1:30pm. Client's emergency contact was notified by staff at 1:41pm.
vesicular rash, which was diagnosed as severe herpes zoster or shingles; The vaccine did not prevent shingles as intended; Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age or gender. The patient's medical history, concurrent conditions and concomitant medication use were not provided.   In 2013, the patient was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) (dose, strength, administration route, anatomical location, lot number and expiration date were not reported) for routine adult health maintenance and for the long-term prevention of shingles.The reporter stated that the vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. Later in 2015, the patient was treated for the onset of a vesicular rash, which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the zoster vaccine live (ZOSTAVAX), and/or despite receiving zoster vaccine live (ZOSTAVAX) for long-term prevention of shingles. The patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and would continue to suffer significant medical expenses, and pain and suffering, and other damages.
Presented with SOB, cough, +Covid x2 weeks; previously d/c from hospital Covid floor 4 days ago; admitted with Covid PNA; treated with supplemental O2 (was on 5 L PTA), merrem, vanc, 1 dose remdesivir (out of time frame for remdesivir), Vit D, steroids, Overall patient symptoms improved and has remained stable
Shivering; weakness; Out of work - extreme fatigue; Uncontrollable shaking; Violent Headache for almost 2 months/ severe headache; Uncontrollable aches; Sleepless due to unconfortable shaking; This spontaneous case was reported by a nurse and describes the occurrence of ASTHENIA (weakness), TREMOR (Uncontrollable shaking), INSOMNIA (Sleepless due to unconfortable shaking), CHILLS (Shivering) and HEADACHE (Violent Headache for almost 2 months/ severe headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 02bL20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hives since 06-Jun-1997. Concomitant products included HYDROXYZINE HYDROCHLORIDE (ATARAX [HYDROXYZINE HYDROCHLORIDE]) for Itching.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INSOMNIA (Sleepless due to unconfortable shaking). On 25-Jan-2021 at 8:00 PM, the patient experienced TREMOR (Uncontrollable shaking), HEADACHE (Violent Headache for almost 2 months/ severe headache) and MYALGIA (Uncontrollable aches). On 26-Jan-2021, the patient experienced ASTHENIA (weakness) and FATIGUE (Out of work - extreme fatigue). On an unknown date, the patient experienced CHILLS (Shivering). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) for Adverse event, at an unspecified dose and frequency. At the time of the report, ASTHENIA (weakness), TREMOR (Uncontrollable shaking), INSOMNIA (Sleepless due to unconfortable shaking), CHILLS (Shivering), MYALGIA (Uncontrollable aches) and FATIGUE (Out of work - extreme fatigue) outcome was unknown and HEADACHE (Violent Headache for almost 2 months/ severe headache) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Did Moderna COVID-19 vaccine cause clotting or bleeding issue and patient like to get a feedback on the animal studies and past 15 year how their brains looked in autopsy.   This case was linked to MOD-2021-095404 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Medical history added, concomitant medication added, treatment medication added, event added and patient demographics added.
Swollen at site of injection 10 days after, itchy and raised like a giant mosquito bite. Then,  giant red splotch taking up 1/3 of upper arm, probably 5 inches tall by 4 inches wide. Faded of the course of 4-5 days. Turned into a ring, looking like ringworm. Eventually faded completely, no remaining marks.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Dec2020 at 07:00 as dose 1, single (Lot number: eh9899), as dose 2, single (Lot number: EL8982), in right arm, on 14Oct2021 at 20:00 as dose 3 (booster), single (Lot number: FF2590), in right arm and on 24Mar2022 at 20:00 as dose 4 (booster), single (Lot number: FM9992), in right arm for covid-19 immunisation. The patient's relevant medical history included: "hypothyroidism migraines" (unspecified if ongoing); "hypothyroidism migraines" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID, start date: 01Jun2022, stop date: 05Aug2022. Past drug history included: Cefuroxime, reaction(s): "Known allergies: cefuroxime". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19; COVID 19 Treatment included Paxlovid from 06Jul2022 to 10Jul2022.; Sender's Comments: The contribution of the suspect drug to the onset of events cannot be ruled out since drug efficacy varies from one patient to another and affected by different factors.
This spontaneous report received from a healthcare worker refers to unspecified patients of unknown age. No information about medical history, concurrent conditions and concomitant medications were reported. The reporter stated that on an unknown date unknown number of unspecified patients at office had occasionally been administered with GARDASIL (therapy start dates, dose strength, frequency, route was not reported) at schedules other than what is in the prescribing information. No adverse effects reported. The outcome of events reported is unknown. No product quality complaint was involved. This case is linked to the case 1408USA009648 via same reporter link. Additional information has been requested.
UNUSUAL ARM SWELLING AND TINGLING ALL THE WAY DOWN TO HER FINGERS. ALSO FELT "FOGGY"
01/17/2023, around 06:00PM, I felt like I had a urinary tract infection. On 01/25/2023, I went to the doctor and had a CT scan to check for a kidney stone, I had bloodwork. I began to have pain, shortness of breath on 02/15/2023. I went to the doctor on 02/17/2023, she sent me to the emergency department. They did a chest X-ray and other tests. I have Calcified Granulomas on my lungs. I have joint pain in hips, knees, elbows. I took doxycycline. I take an herbal anti-inflammatory. I have a referral to an allergist and a rheumatologist. I saw a urologist as well.
Sudden acute and intense pain in shoulder and neck about a week after the shot. Pain lasted 2-3 week before tapering off. Significant muscle weakness in left arm for 4 months. Healed on its own. Ibuprofen taken for pain management. Diagnosis of Parsonage-Turner Syndrome.
No adverse reaction or side effects. Pt. was given a extra dose of mcv4 that was not needed since she had all ready received one in 10/19/2022.
eye infection; This spontaneous case was reported by a consumer and describes the occurrence of EYE INFECTION (eye infection) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced EYE INFECTION (eye infection). At the time of the report, EYE INFECTION (eye infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  No treatment details were provided.
Red rash on neck (like a deep sunburn), rash on back of both knees, skin blotches on arms and legs. No treatment and ongoing, as of today.
4 days after received 2nd dose of vaccine, severe pain in upper back and legs. This has lasted 10 days so far. Went to ER April 7 for pain. They took blood, did chest x ray, lower back x ray and EKG. All results normal. Told to take tylenol. On Thursday, April 8, went to chiropractor
Pt vaccinated with Influenza developed rt brachial plexopathy - primarily in distribution of axillary nerve.
Information has been received from a nurse referring to a male patient of unknown age. Information about concurrent condition, concomitant medication and medical history was not provided. On 24-OCT-2018, the patient was vaccinated with an expired dose of VAQTA lot # N020689, expiration date 22-OCT-2018, intramuscularly for prophylaxis. No adverse effects.
After the vaccine, he had hives noted on inner sides of upper arms down to his antecubital areas and on his anterior and medial proximal thighs.  Administered 10mg of cetirizine, which lessened the hives. Advised cetirizine qhs for a few days to a few weeks until the rash resolves, hydrocortisone cream 2.5% if the rash reoccurs.
Day after vaccine broke out in generalised red bumps all over body, non itchy, sparing palms and soles. No fever, no malaise.
Information has been received from a nurse practitioner concerning a 14 year old female with a history of anaemia who on 28-FEB-2008 was vaccinated intramuscularly in the left deltoid with her first dose of Gardasil (Lot # reported as 1758O).  About 2 days after the vaccination, the patient developed a rash on her abdomen, chest and shoulder.  There was no shortness of breath, no hives, no fever or no other symptoms.  The patient sought unspecified medical attention in the office.  No other information is available.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 4/14/2008. Initial and follow up information has beenreceived from a nurse practitioner concerning a 14 year old female with a history of anaemia, and no know allergies, who on 28-FEB-2008 was vaccinated intramuscularly in the left deltoid with her first dose of GARDASIL (Lot # reported as 1758O). On 02-Mar-2008, about 2 days after the vaccination, the patient developed erythematous macular-papular eruption on her abdomen, chest and shoulders. It was minimally pruritic. There was no shortness of breath, no hives, no fever or no othersymptoms. On 12-MAR-2008, the patient was seen for evaluation of the rash for the first time. The patient was given CLARITIN and hydrocortisone cream (not specified). On 14-MAR-2008, two days later, the rash cleared. Additional information is not expected.
Patient felt faint, numbness to L foot, and pressure to forehead. Pt stated to have butterfly feelings and an increase in anxiety. Pt did not have any injuries. Pt did not demonstrate any paleness or flushed skin tone.  Adverse event occurred at 1625.
chills, muscle pain, join aches, elevated heart rate, weakness, headache @ 12 hours after injection took 650mg tylenol, able to fall asleep awoke again with sweats (did not take temperature)  able to fall asleep, slept a total of 18 hours still with headache, weakness, fatigue on wakening, took 325 mg tylenol and 200 mg advil symptoms resolved approximately 25 hours after injection
ED to Hosp-Admission Discharged 9/14/2021 - 9/19/2021 (5 days) Hospital Presenting Problem/History of Present Illness/Reason for Admission Shortness of breath [R06.02] Acute on chronic respiratory failure with hypoxia    Hospital Course   63 y.o. male with a PMHx of COPD not on home O2, HFpEF, A. fib on anticoagulation, hyperlipidemia, hypertension, GERD, anxiety presented on 9/14/2021 to Hospital because of shortness of breath. Patient was recently admitted to  Hospital on 8/9 for multifocal pneumonia, respiratory failure requiring intubation for 5 days, complicated by CVA and A. fib with RVR, completed IV antibiotics and course of steroids and discharged on 9/12. Patient was diagnosed with COVID-19, with supporting CXR and CTA Chest findings, no PE was found. He was placed on 6L O2 NC. Patient also met severe sepsis criteria, and was empirically started on Vancomycin and Cefepime. He was started on a 10-day course of Decadron, 5-day course of Remdesivir. Vancomycin and Cefipime were discontinued once blood cultures were negative at 48 hours. Patient completed 5-day course of Remdesivir, IV Decadron was transitioned to PO Decadron to be completed outpatient by 9/23/21. Patient was weaned off oxygen and breathing well on room air. PT recommended home with home health.    He will need follow up with the Heart Failure team, for which an appointment is already made for 10/15/21. He will also need follow up with Pulmonology to set up PFTs in 4-6 weeks. He will also need follow up with Gastroenterology to manage his untreated Hepatitis C and Barrett's Esophagus found on previous EGD. He has an AFP lab pending to screen.     Hospital Problems          POA    * (Principal) Acute respiratory failure with hypoxia  Yes         Mixed anxiety depressive disorder Yes         Chronic hepatitis C virus infection  Yes         Chronic obstructive pulmonary disease  Yes         Severe sepsis Yes         COVID-19 virus infection Yes         Leukocytosis Yes         Demand ischemia  Yes         Left shoulder pain Yes         Fracture of left humerus Yes         Gastroesophageal reflux disease without esophagitis Yes         Microcytic anemia Yes         Hx of gout Yes         Paroxysmal atrial fibrillation  Yes         On apixaban therapy Not Applicable         Essential hypertension Yes         Mixed hyperlipidemia Yes         Chronic heart failure with preserved ejection fraction  Yes         Barrett's esophagus Yes         Other cirrhosis of liver  Yes         Smoker unmotivated to quit Yes         Esophageal thickening Yes         Hilar lymphadenopathy Yes         Mediastinal lymphadenopathy Yes
Woke up the following injection with discomfort and general aches and body pains which went away in a few days except the (L) shoulder which became more and more painful.  Pain moved across arm when moved at first, then started going down arm, affecting ability to moved arm and hold things in hand.  Had swelling from elbow to shoulder.
Patient received Moderna vaccine on 1/12/21. Due for second dose Moderna 2/17/21. Moderna vaccine was not available on 2/17/21 at site - patient stated he received Pfizer for first dose and inadvertently received Pfizer for second dose when Moderna was due
fever for multiple days which the GP dr prescribed antibiotic. the 8 days later abdominal pain. then shortness of breath,then chest pain. admitted to hospital wednesday sep152021
Parsonage Turner syndrome in left shoulder as confirmed by MRI and clinical exam.   Significant pain for approx 1 week followed by severe weakness in suprasponatus and infrasponatus muscles.
Patient ran fever of 100.5 degrees F that night after receiving FLUARIX and PNEUMOVAX 23 vaccines earlier that morning. Patient also reported a headache that night. Both headache and fever resolved the following morning.
48 year-old man referred for admission from outpatient echo appointment after finding of large pericardial effusion.   Patient's history includes iron-deficiency anemia from hiatal hernia and season allergies. Was in usual state of health until received second Pfizer mRNA Covid-19 vaccine 5/18/21. A few days later developed cough, 'brain fog,' dyspnea. Had remote outpt visit and treated with abx for sinusitis. Covid test was negative 5/28/21. Symptoms worsened and developed swelling of legs and abdomen, worse exertional dyspnea and had to sleep sitting up due to orthopnea.    Began on lasix 20 PO BID as outpt with significant improvement in swelling and other symptoms over past week - thinks he lost 20 lbs. Still feels more bloated than usual.    Had outpt echo as part of eval and sent to ED.   Denies chest pain, palpitations, dizziness. Brain fog is improving. Mildly constipated. No black or bloody stools. No abd pain. PERICARDIAL EFFUSION (6/15/2021)   Assessment: echo Large pericardial effusion noted  mostly post and no echo evidence of tamponade. Smaller in size.   no need for pericardiocentesis  Discharge home on lasix 20 mg daily  Net neg 5.4 L  chest xray looks improved  unbale to get thoracentesis due to not enough fluid Vitals stable
Patient woke up around 9PM with severe itching and then visibly saw hives/welps and went to ER and saw Dr and was given 2 Benadryl's, 2.5 Pepcids, and steroids and patient was discharged at 5AM.
patient described left arm pain that radiates up his arm and into his neck and that he couldn't continue to work the rest of the day on 1/6/21.  recommended that he use ibuprofen for muscle pain and to contact his provider if symptoms increase
2/27 Saturday - vomit and severe body tremors, upper and lower body 2/28 Sunday - body tremors and unaware of situations around him for less than 1 minute 3/6 & 3/7 &3/8- welts and itchy rash over both arms and entire both legs Fatigue and no appetite
Patient was admitted to Medical Center on 08/13/2021 with Covid-19, she was transferred and required intubation and mechanical ventilation.  Patient status continue to decline.  She required 4 codes during the day of 9/2/21 after experiencing worsening bradycardia.  Patient expired on 09/3/21.
Pt noticed small pimple like bumps just below jaw the evening of 7/27/07. She states they are itchy at times. When the rash started to spread down her neck on 7/31/07 she called me to report it. She denies SOB and c/o fatigue as only other symptom. Advised Benadryl. 8/2/07 Rash spread to arms and legs, but Benadryl seemed to help.
he got a Herpes looking rash all around his mouth, lip, chin.; he got a Herpes looking rash all around his mouth, lip, chin.; he got a Herpes looking rash all around his mouth, lip, chin.; This is a spontaneous report from a non-contactable consumer. A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: Unknown), via unspecified route of administration, on an unspecified date as a dose 2, single for COVID-19 immunization. The patient medical history and concomitant medication were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: Unknown), via unspecified route of administration, on an unspecified date as a dose 1, single for COVID-19 immunization (After the first shot patient felt sick with flu symptoms for several days). On an unspecified date the patient got a herpes looking rash all around his mouth, lip and chin. Patient stated that he has not felt the same since. The outcome for all the reported events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.